Differences in secukinumab pain response in AxSpA pts based on HLA-B27 sub-types.
Homozygous group = more uveitis, arthritis, enthesitis, male
Abs#917
#ACR21 @RheumNow
https://t.co/3TL9PdS4xx https://t.co/QQ0Tdye1Z9
Links:
Efficacy of Secukinumab and HLA-B27 Subtypes: Results from a Phase IIIb Randomi…
https://bit.ly/3bPFY6M
09-11-2021
